Response to ritlecitinib with or without narrow-band UVB add-on therapy in patients with active nonsegmental vitiligo: results from a phase 2b extension study
{{output}}
Background: Ritlecitinib demonstrated efficacy in a phase 2b trial of nonsegmental vitiligo. Objective: To evaluate the efficacy and tolerabili... ...
